Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 7Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Burkitt Lymphoma 4Ovarian Neoplasms 3Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Lung Neoplasms 2Head and Neck Neoplasms 2Xerostomia 1Thyroid Carcinoma, Anaplastic 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Recurrence 1Prostatic Neoplasms 1Previously Treated Non Small Cell Lung Cancer 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain 1Osteosarcoma 1Neutropenia 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Multiple Myeloma 1

Interventions

Vincristine 2Temozolomide 2Irinotecan 2Doxorubicin 2Cyclophosphamide 2Bone Marrow Transplantation 2robatumumab 1pegfilgrastim 1palbociclib 1lexatumumab 1ganitumab 1disaccharide tripeptide 1delta 24-sterol reductase 1copanlisib 1bempegaldesleukin 1Thiotepa 1Radiosurgery 1Plicamycin 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Melphalan 1Magnetic Resonance Spectroscopy 1Interferon-gamma 1Immunotherapy, Adoptive 1INCB059872 1IL32 protein, human 1Granulocyte Colony-Stimulating Factor 1Genistein 1Filgrastim 1FANG vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sarcoma, Ewing × pegfilgrastim × Clear all
NCT01313884 2017-11-24

Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma

Stanford University

Phase 2 Terminated
3 enrolled 7 charts
Sarcoma

Bone Neoplasms, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡